Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | FASN | P49327 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29116361 | 0.71 | FASN (0.54) | FAAHFASNTSHRMEN1ALDH1A1 | |
| SCHEMBL17517801 | 0.71 | MMP1 (0.31) | — | |
| SCHEMBL20774476 | 0.70 | CES2 (0.52) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL20854580 | 0.70 | CES2 (0.52) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL20854579 | 0.70 | CES2 (0.52) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL20854578 | 0.70 | CES2 (0.52) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL20854575 | 0.70 | CES2 (0.52) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL20854584 | 0.70 | CES2 (0.52) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL20854574 | 0.70 | CES2 (0.52) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL21660228 | 0.70 | CES2 (0.52) | TSHRMEN1ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023056033-A1 | LIPID NANOPARTICLE COMPOSITIONS FOR DELIVERING CIRCULAR POLYNUCLEOTIDES | ORNA THERAPEUTICS, INC. (US) | 2023-04-06 | — | — | WO | disclosed |